Institute for Research in Biomedicine
USPTO PatentsView assignee record - 61 granted patents across 12 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).
The verdict
According to USPTO PatentsView, Institute ranks #5,599 of 49,997 tracked US assignees by granted-patent volume, with 61 patents across 12 technology areas.
- #5,599
- of 49,997 US assignees by volume
- Top 31%
- by Innovation Score (42.1/100)
- 21.1
- avg claims per patent
- -30%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R5599 · Foreign Corporation #5,599 · 61 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL
- GRANTS-SMALL 61 grants
- UPPER-Q #5,599/49,997
- PHOTO-FINISH Harbin Engineering…
- CPC-FOCUS C07K · 12 areas
- INNOV-PAR 42.1/100
- CLAIMS-DENSE 21.1 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DOWN -30% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Harbin Engineering University (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Institute’s 42.1 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Institute
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- DSG Technology… · near
DSG Technology… · near
42 score
- Federal Law… · near
Federal Law… · near
42 score
- Institute for… · this assignee
Institute for… · this assignee
42 score
- Liqxtal Technology · near
Liqxtal Technology · near
42 score
- Wi-LAN · near
Wi-LAN · near
42 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Institute's Innovation Score is 42.1/100 (top 31% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Institute?
Each dot is one of Institute’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Institute’s own 21.1 claims/patent is ABOVE the 7.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Institute's grants concentrate
Institute for Research in Biomedicine is a focused PatentsView assignee: 12 CPC subclasses with 98.4% of grants classified under C07K (Peptides). Peak complete grant year is 2016 (9 grants) versus a trough of 1 in 2022. By volume, Institute sits between Harbin Engineering University and Lesaffre ET Compagnie.
Institute's three-year grant acceleration
From 2019–2021 to 2022–2024, Institute for Research in Biomedicine moved from 20 to 9 grants (0.45x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.
Who files at Institute's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Harbin Engineerin…
Harbin Engineering University
61 patents
- Infinidat
Infinidat Ltd.
61 patents
- Innovaplant Zierp…
Innovaplant Zierpflanzen GmbH + Co. KG
61 patents
- Inpria
Inpria Corporation
61 patents
- Kolster Holding B…
Kolster Holding B.V.
61 patents
- Kraft Foods R & D
Kraft Foods R & D, Inc.
61 patents
- Kimball Internati…
Kimball International, Inc.
61 patents
- Lesaffre ET Compa…
Lesaffre ET Compagnie
61 patents
- Institute for Res… ◀
Institute for Research in Biomedicine
61 patents
What this shows Institute holds 61 patents at rank #5,598, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Institute
By rank, the assignees closest to #5,598 in granted patent volume.
- Harbin Engineering University #5,594 · 61 patents
- Infinidat Ltd. #5,595 · 61 patents
- Innovaplant Zierpflanzen GmbH + Co. KG #5,596 · 61 patents
- Inpria Corporation #5,597 · 61 patents
- Kolster Holding B.V. #5,599 · 61 patents
- Kraft Foods R & D, Inc. #5,600 · 61 patents
- Kimball International, Inc. #5,601 · 61 patents
- Lesaffre ET Compagnie #5,602 · 61 patents
Leaders in C07K (Peptides)
Other assignees with the most granted patents in Institute's primary technology class.
- The Regents of the University of California 894 in class
- Regeneron Pharmaceuticals, Inc. 824 in class
- Immatics Biotechnologies GmbH 678 in class
- Genentech, Inc. 565 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 513 in class
- The Trustees of the University of Pennsylvania 501 in class
- Novartis AG 407 in class
- The Board of Trustees of the Leland Stanford Junior University 400 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Institute, neither rank-band nor same-CPC leaders (those blocks stay above). In C07K (Peptides), Institute ranks #138 of 3,615 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (42 here).
Similar claim depth
Nearest assignees by average claims per patent (21.1 here).
Institute's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
42 Top 31% higher than 69% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 5 | 8.2% |
| 2016 | 9 | 14.8% |
| 2017 | 8 | 13.1% |
| 2018 | 5 | 8.2% |
| 2019 | 6 | 9.8% |
| 2020 | 6 | 9.8% |
| 2021 | 8 | 13.1% |
| 2022 | 1 | 1.6% |
| 2023 | 7 | 11.5% |
| 2024 | 1 | 1.6% |
| 2025partial year | 5 | 8.2% |
Which technologies does Institute for Research in Biomedicine patent most?
Top 12 of 12 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Institute for Research in Biomedicine's patent record in context - here's where to go next.
- Institute for Research in Biomedicine's lead technology class is C07K (Peptides), 98.4% of its portfolio - see every assignee active in that class. Explore C07K
- Ranked #5,599 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Institute for Research in Biomedicine against Harbin Engineering University, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 42.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.